Sentences with phrase «of financial aid programs»

Whether you completed dental assistant programs online or in - person, don't forget to take advantage of financial aid programs.

The answer is the right combination of financial aid programs that can help you manage the costs involved in obtaining your degree.

Over the past decade, as college costs have skyrocketed, the state has introduced a myriad of financial aid programs specific -LSB-...]

There are a number of financial aid programs designed to help you afford a higher education.

By submitting the FAFSA, students are able to apply for a variety of financial aid programs, including federal grants and student loans.

Other work examines the effects of financial aid programs, the impact of postsecondary remediation on academic preparation, and how to better support families saving for college.

You can also look for work opportunities that aren't part of a financial aid program.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Keep in mind though that not all schools participate in the Perkins Loan Program, so be sure to check with your school's (or prospective school's) financial aid office to see if this type of student loan is available to you.

The crux of the issue is that while the financial benefits of these [loan and aid] programs are clear, the increasingly burdensome regulatory requirements are troubling for faith - based institutions.

Financial aid is available, and Elementary and Early Childhood program students have the option to apply their Sunbridge education toward earning a fully - accredited MEd through our partnership with The State University of New York's Empire State College.

The Waldorf School of Baltimore does not discriminate on the basis of sex, race, color, religion, sexual orientation, or national or ethnic origin in the administration of its educational program, admission policies, financial aid policies, employment practices and other school - administered programs.

Our financial aid and sibling discount programs support this goal, and the families participating in these programs have contributed significantly to the economic diversity of the school as well as to its spiritual and social growth.

Formed against a background of economic curtailment on welfare spending and a huge increase in the number of HIV and AIDS cases, Wola Nani initiated programs to help HIV + people in the local community cope with the emotional and financial strains brought about by HIV and AIDS.

The Cincinnati Waldorf School's Board of Trustees» responsibilities include providing support and aid to the faculty in implementing a Waldorf educational program, to authorize major business and financial decisions, to appoint chairs and members of standing committees and to adopt the budget for the Cincinnati Waldorf School.

The public is invited and proceeds will benefit the Parks Foundation of Highland Park SMILE Grant - in - Aid program which provides recreation grants for local families in need of financial assistance.

Proceeds benefit the Parks Foundation of Highland Park SMILE Grant - in - Aid program which provides recreation grants for local families in need of financial assistance.

In 1992, the SMILE Grant - in - Aid program was created to enable families in need of financial assistance the opportunity to participate in Park District programs.

Many schools plan to add new student programs and services next year, aided by millions of dollars in fresh financial assistance from Albany, as well as reductions in state pension costs.

The Higher Education Services Corporation, which runs the state's Excelsior Scholarship, Tuition Assistance Program (TAP) and other financial aid programs, would get an increase of $ 80 million — 7.3 percent — to $ 1.18 billion.

Sponsored by Assemblymember Carmen De La Rosa of Manhattan, the measure would allow students brought into the country as children to seek state financial aid for higher education, including the Excelsior Scholarship program that makes tuition at state colleges free for low - income and middle - class students.

Money from the fund supports some of the state's most important safety net programs --» the State's Medicaid program, Family Health Plus, workforce recruitment and retention, the Elderly Pharmaceutical Insurance Coverage (EPIC) program, Child Health Plus (CHP), Graduate Medical Education, AIDS programs, disproportionate share payments to hospitals and other various public health initiatives,» according to the state's financial plan.

«They tend to be relatively cost - effective for sponsoring governments because each of the programs use a «last - dollar» model whereby the state subsidizes tuition costs after the student has exhausted all other available state and federal financial aid.»

Legislation U.S. Rep. Elise Stefanik, R - Willsboro, introduced May 17 to extend the federal Perkins Loan college financial aid program for two years gained momentum as the House returned from recess on Tuesday, picking up a dozen new co-sponsors, according to the Library of Congress government information web site.

Had it passed, New York would have become the fifth state to enact the DREAM Act, which would have allowed state financial aid programs to cover the college kids of undocumented immigrants.

The only public evidence of Parent Workshop programming is a four - minute YouTube video that shows Sparks giving a college financial - aid workshop to high - school students.

Schumer called the bill a critical first step in the fight against heroin and opioids, expanding the availability of naloxone — also known as narcan — to law enforcement and first responders, improving prescription drug monitoring programs, shifting resources to identifying and treating incarcerated people suffering from addiction, and prohibiting the Department of Education from questioning students about prior drug convictions on financial aid forms.

She has instead sponsored several bills to expand the state's Tuition Assistance Program and other existing streams of financial aid for college students who are citizens.

State departments of education and colleges offering the programs can provide information on financial aid, and some states, such as Minnesota and North Dakota, have loan repayment programs for teachers willing to work in areas of critical need.

Reporting from Berlin, Vogel wrote «that the federal government will take over the full cost of the country's financial aid program for university students — which will amount to a $ 1.2 billion savings for state budgets each year.»

At a meeting on Monday evening, Angela Merkel and leaders of her party's coalition partners agreed that the federal government will take over the full cost of the country's financial aid program for university students — which will amount to a $ 1.2 billion savings for state budgets each year.

[BOX 3: Grants and Contracts] Financial Statements, 1957 - 1959 Financial Reports, 1957 - 1959 Financial Statements, 1958 Financial Reports 1960-1961 1962 1963 1964-1965 1966-1967 Report on Review of Source Data Preparation for Accounting Purposes, Oct. 1961 AAAS Budgets, 1968 - 1969 Financial Reports, 1968 - 1969 Financial Statements and Accountant's Opinion, 1969 Financial Statements and Accountant's Opinion, 1970 Financial Reports, 1970 - 1971 Financial Reports, 1972 Financial Reports from Operations, 1979 Budget Proposal for Fiscal Year 1974 and Projections to 1963 Report for Examination of Financial Statements and Additional Information, 1983 - 1984 Closed out Funds and Stocks AAAS Grants Committee, 1955 AID Audit - Mexico City, 1974 Asia Foundation, 1955 - 1975 Boston Concerts Carnegie Corp. - Grant to AAAS for Science Teaching Improvement Program Graham Chedd - Contract [3 folders], 1973 - 1977 DOS - AID Irene Tinker, 1973 - 1977 RISM Research for the Study of Man, 1973 - 1977 Smithsonian, 1971 - 1977 Audit, 1973 - 1977 Close Out, 1976 - 1978 GE Grant - Regional Consultants on Science Teaching, 1956 Gordon Marshall, Exhibits Contract, 1952 National Endowment of the Arts, 1973 NSF Grant - Soviet Science, 1952 Training Talented Students, 1955 Travelling High School Library, 1956 Gordon Conference on Teacher Education, 1956 Junior Academies Workshop, 1957 Proposal to NSF for Development of Science Teaching Materials for Elementary and Junior High Schools, 1961 Progress Report to the NSF on the Holiday Science Lecture Program, 1963 Proposal to the NSF for 1964 Visiting Foreign Staff Project, 1963 NSF - US - Japan Comparative Science Program, 1963 NSF - US - Japan Cooperative Science Program, 1964 WGBH, 1972 Willis Shapley, Contract Agreement, Oct. 1978 DHEW - Barrier Free Meetings, Oct. 1977 CBS News - Conquest Program Series, 1959 MISCO Contract - original, 1972 Basic Books Publishing - New Roads to Yesterday, 1963 - 1966

[Box 9] OIS - China - Chinese Science and Technology Policy Delegation Visit, 1978 Zhongshan University Delegation Visit, 1979 AAAS Popularization of Science Delegation to China, 1980 CAST Science Writers Delegation to US, 1981 AAAS Environmental Planning Delegation to China, 1981 US - China Conference on Energy Resources and Environment, 1982 Interferon Study (Proposed), 1982 CAST Delegation to US, 1982 CAST Quality Control Delegation to US, 1982 Rumenant Productivity Symposium - US Papers, 1983 Rumenant Productivity Symposium - Chinese Papers, 1983 Photo Album of Address by Song Jian, 1985 AAAS Board of Directors Delegation to China, 1985 Chinese Delegation Visit (IIE), 1986 US Fish and Wildlife Service Delegation to China, 1986 FASAS International Climate Change Symposium (Proposal), 1986 CAST Delegation to US, 1986 Background Political Information, 1987 Law / Science Short Course (Proposal), 1987 Collected Information and Papers on Chinese Water Management, 1987 CAST Water Management Delegation to US, 1987 AAAS Water Management Delegation to China, 1987 AAAS Water Management Delegation to China - Follow - up, 1988 CAST Petrochemical Engineer Delegation to US (Proposal), 1987 Pacific Rim Symposium (Proposal), 1987 Science and Technology Advising Seminar (Proposal), 1988 - 1989 AAAS / ABA Lawyers and Scientists Delegation to China, 1988 China Symposium at 1989 AAAS Annual Meeting, 1988 - 1989 Medical Instrument Maintenance and Repair, 1989 Fang Li Zhi, 1988 - 1989 Amnesty International Reports on Chinese Arrests, 1989 Correspondence re: June 1989 Events in China, 1989 Consortium of Affiliates for International Programs, 1989 China - FASAS Symposium on Environmental Protection in Developing Countries, 1989 FASAS Symposium Chinese Papers, 1989 PRC Joint Commission Visit, 1989 Tibet, 1987 Liz Levey Misc Correspondence, 1982 - 1990 Chinese Code of Ethics, 1986 China Tech Company Information, (undated) AAAS / CAST Exchange Programs, 1978 - 1987 Correspondence with CAST International Director Wang Zheng, 1981 - 1982 Correspondence with CAST, 1981 - 1989 James Hartnett Complaint to CAST, 1988 - 1989 Chinese Academy of Sciences, 1987 Hong Kong Association for the Advancement of Science and Technology, 1987 - 1988 Correspondence with Chinese Embassy, 1982 - 1987 NAS China Committee, 1982 - 1986 Financial Aid for Chinese Students, 1987 Misc Articles and General Background Information, 1978 - 1989 Misc., 1982 - 1989 Presentation Transparencies, 1988 Elzinga, Aant.

Bloomberg has provided more than $ 1.2 billion, contributing to a school of public health, a physics building, a malaria institute and need - based financial aid programs.

Students who receive financial aid must not only demonstrate financial need, but must also make satisfactory progress toward the completion of their programs of study as determined by MUIH in accordance with federal regulations.

It is unclear how an average of less than $ 300 per student would be sufficient to cover the gaps between tuition and existing financial aid, even given the program's limitations.

In January, the Florida Supreme Court dismissed a legal challenge to the state's Tax Credit Scholarship Program, thereby preserving financial aid opportunities for thousands of low - income students to attend private schools.

Supplemental education loans are credit - based loans that may be borrowed as supplements to the Federal Direct Unsubsidized Loan Program, effectively meeting the gap between your cost of attendance and any financial aid you may receive from the HGSE Financial Aifinancial aid you may receive from the HGSE Financial Aid Offiaid you may receive from the HGSE Financial AiFinancial Aid OffiAid Office.

According to Robert H. Atwell, president of the American Council on Education, the umbrella organization representing several thousand colleges and universities, the 25 - percent cut in federal financial - aid programs proposed by the President would affect «virtually all...

Under her leadership, the school launched the Doctor of Education Leadership Program, a first - of - its - kind practice - based education doctoral program; created a universitywide Ph.D. in Education; established the Urban Scholars Fellowship which provides full tuition to teachers from urban schools; and significantly increased financial aid for master's and doctoral stProgram, a first - of - its - kind practice - based education doctoral program; created a universitywide Ph.D. in Education; established the Urban Scholars Fellowship which provides full tuition to teachers from urban schools; and significantly increased financial aid for master's and doctoral stprogram; created a universitywide Ph.D. in Education; established the Urban Scholars Fellowship which provides full tuition to teachers from urban schools; and significantly increased financial aid for master's and doctoral students.

Moreover, it will continue to monitor specific data related to financial aid, degree programs, attrition rates, and completion and graduation rates attributed to the quality of education and the effectiveness of higher education institutions.ConclusionThe U.S. Department of Education and other government agencies support IPEDS data collection to ensure accountability and transparency in higher education.

According to the Higher Education Act (HEA) of 1965, all institutions receiving Title IV funds must submit specific data about their educational programs, student population, enrollment, attrition, and completion rates, staff and faculty, financial information, tuition and fees, and allocation of all student financial aid (NCES, n.d.) IPEDS HistoryIn 1995, NCES established the National Postsecondary Education Cooperative (NPEC) as a «voluntary organization that encompasses all sectors of the postsecondary education community including federal agencies, postsecondary institutions, associations, and other organizations interested in postsecondary education data collection» (NPEC, n.d., p. 4).

It is thus fair to ask: what precisely is the added value of FWS, when other federal programs provide more substantial and better - targeted forms of financial aid, and when the private sector already provides ample opportunities for students to work?

The House of Representatives last week approved a bill extending student - financial - aid programs in the Higher Education Act through June 30.

Simon's Rock College of Bard, a small, well - regarded liberal - arts institution in western Massachusetts, has unveiled an unusual financial - aid program for students completing the sophomore year of high school.

In that regard, this section covers four topics: University participation in gratuidad and enrollment changes observed in its initial years; the extent to which gratuidad replaced existing financial aid; an econometric study that suggests low - income students will be crowded out of more selective universities; and finally, the revenue pressures the program has imposed on universities and how that may threaten quality.

Much will be learned from these experiences in the years ahead, but for the time being one immediate takeaway merits repeating: Local policy prerogatives and dire financial conditions trumped federal pleas for reform and led to the spending of massive amounts of aid on preserving the status quo and protecting existing jobs and programs.

Since Harvard University participates in the Federal Direct Loan Program this is the only supplemental loan that is recommended by the HGSE Financial Aid Office, however students may select any supplemental loan of their liking.

Unlike last - dollar aid programs that only cover the gap between a student's financial aid package and the cost of attendance, the Dell Scholars Program allocates $ 20,000 to each selected student.

During their time in EMERGE, our students set long - term goals, attend SAT preparation classes, take out - of - state college tours, work one - on - one with a program manager through the application process, and attend weekend workshops on interviewing, financial aid, and the transition to college.